Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.

Thrombosis research - 1 Aug 2010

Harlev Dan, Zaidman Irina, Sarig Galit, Ben Arush Myriam Weyl, Brenner Benjamin, Elhasid Ronit

Abstract excerpt

INTRODUCTION: Thrombotic events (TE) are well documented in patients with acute lymphoblastic leukemia (ALL). They occur due to a combination of disease, host and treatment-related risk factors. Low molecular weight heparin (LMWH) has been found to be effective and safe in children with ALL during L-asparaginase treatment. At present, whether or not to give primary anticoagulant prophylaxis for TE during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asparaginase

Share to Child, Preschool

Share to Infant

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Thrombophilia

Source

Identifiers

PMID: 20546854
DOI: 10.1016/j.thromres.2010.04.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.PMID 20546854Read ↗

Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.Semantic proximity Read ↗

The risk factors for thrombosis in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.Semantic proximity Read ↗

Thrombosis in children with acute lymphoblastic leukemia Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment.Semantic proximity Read ↗

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.Semantic proximity Read ↗

Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.Semantic proximity Read ↗

Inherited thrombophilia and risk of thrombosis in children with cancer: a single-center experienceSemantic proximity Read ↗

Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.Semantic proximity Read ↗

Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors.Semantic proximity Read ↗

2 Cases of Pegylated Asparaginase-Associated Cerebral Venous Sinus Thrombosis in Children: Clinical Analysis and Literature ReviewSemantic proximity Read ↗

Update on the Use of L-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Evaluation of thrombotic children with malignancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.